Literature DB >> 2017983

Clinical correlates of the molecular and cellular actions of magnesium on the cardiovascular system.

R A Reinhart1.   

Abstract

Magnesium is a ubiquitous element that participates in metabolic processes essential for life. Magnesium acts as a metallic cofactor in more than 300 enzymatic reactions; notably it is essential for all reactions requiring ATP. Magnesium also functions as a transmembrane and intracellular modulator of other ions. Altered magnesium homeostasis, particularly a deficiency, can cause alterations in metabolic functions that result in clinically recognizable events. Recognition of magnesium deficiency is problematic, since there is no test that will reliably and consistently detect this condition. A high index of suspicion for magnesium deficiency is necessary and treatment should be given when indicated. This article reviews the molecular and cellular actions of magnesium and correlates these basic scientific findings with clinically recognized cardiovascular events in humans. In addition, management guidelines are delineated.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2017983     DOI: 10.1016/0002-8703(91)90160-j

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  15 in total

1.  Serum and erythrocyte magnesium in critically ill patients?

Authors:  R A Reinhart
Journal:  Intensive Care Med       Date:  1996-08       Impact factor: 17.440

Review 2.  Role of magnesium sulfate in seizure prevention in patients with eclampsia and pre-eclampsia.

Authors:  J Anthony; R B Johanson; L Duley
Journal:  Drug Saf       Date:  1996-09       Impact factor: 5.606

Review 3.  Do diuretics cause magnesium deficiency?

Authors:  D L Davies; R Fraser
Journal:  Br J Clin Pharmacol       Date:  1993-07       Impact factor: 4.335

Review 4.  [Clinico-electrophysiologic effects of magnesium, especially in supraventricular tachycardia].

Authors:  E G Vester
Journal:  Herz       Date:  1997-06       Impact factor: 1.443

5.  Premedication with intravenous magnesium has a protective effect against cisplatin-induced nephrotoxicity.

Authors:  Yoshitaka Saito; Masaki Kobayashi; Takehiro Yamada; Kumiko Kasashi; Rio Honma; Satoshi Takeuchi; Yasushi Shimizu; Ichiro Kinoshita; Hirotoshi Dosaka-Akita; Ken Iseki
Journal:  Support Care Cancer       Date:  2016-10-03       Impact factor: 3.603

6.  Magnesium metabolism and its disorders.

Authors:  R Swaminathan
Journal:  Clin Biochem Rev       Date:  2003-05

7.  Selenium concentration and glutathione peroxidase activity in selenium and magnesium deficient rats.

Authors:  Z Zhu; M Kimura; Y Itokawa
Journal:  Biol Trace Elem Res       Date:  1993 May-Jun       Impact factor: 3.738

8.  Hyperacute therapies for childhood stroke: a case report and review of the literature.

Authors:  Jose Irazuzta; Kevin J Sullivan
Journal:  Neurol Res Int       Date:  2010-08-19

Review 9.  Magnesium in stroke treatment.

Authors:  K W Muir
Journal:  Postgrad Med J       Date:  2002-11       Impact factor: 2.401

10.  Circulating Serum Magnesium and the Risk of Venous Thromboembolism in Men: A Long-Term Prospective Cohort Study.

Authors:  Setor K Kunutsor; Jari A Laukkanen
Journal:  Pulse (Basel)       Date:  2021-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.